Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Pantophlet

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Biochemistry|February 11, 2004
Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitopeRamalakshmi Darbha, Sanjay Phogat, Aran F Labrijn, et al.
Chemistry & Biology|April 27, 2010
Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffoldsRena D Astronomo, Eiton Kaltgrad, Andrew K Udit, et al.
Journal of Molecular Biology|April 21, 2007
Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodiesErica Ollmann Saphire, Marinieve Montero, Alfredo Menendez, et al.
Journal of Chemical Information and Modeling|March 17, 2023
Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent InhibitorsOlivia Garland, Anh-Tien Ton, Shoeib Moradi, et al.
Journal of Virology|November 27, 2004
A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variationDavid H O'Connor, Adrian B McDermott, Kendall C Krebs, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccineMark A Brockman, Francis Mwimanzi, Yurou Sang, et al.
The Journal of Infectious Diseases|December 10, 2021
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older AdultsMark A Brockman, Francis Mwimanzi, Hope R Lapointe, et al.
The Journal of Infectious Diseases|May 11, 2022
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapyZabrina L Brumme, Francis Mwimanzi, Hope R Lapointe, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Biochemistry|February 11, 2004
Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitopeRamalakshmi Darbha, Sanjay Phogat, Aran F Labrijn, et al.
Chemistry & Biology|April 27, 2010
Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffoldsRena D Astronomo, Eiton Kaltgrad, Andrew K Udit, et al.
Journal of Molecular Biology|April 21, 2007
Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodiesErica Ollmann Saphire, Marinieve Montero, Alfredo Menendez, et al.
Journal of Chemical Information and Modeling|March 17, 2023
Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent InhibitorsOlivia Garland, Anh-Tien Ton, Shoeib Moradi, et al.
Journal of Virology|November 27, 2004
A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variationDavid H O'Connor, Adrian B McDermott, Kendall C Krebs, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccineMark A Brockman, Francis Mwimanzi, Yurou Sang, et al.
The Journal of Infectious Diseases|December 10, 2021
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older AdultsMark A Brockman, Francis Mwimanzi, Hope R Lapointe, et al.
The Journal of Infectious Diseases|May 11, 2022
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapyZabrina L Brumme, Francis Mwimanzi, Hope R Lapointe, et al.
Pageof 6